Skip to main content

Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis

Abstract

Background

Patients with Hirschsprung disease are at risk for Hirschsprung-associated enterocolitis (HAEC), an inflammatory disorder of the bowel that represents the leading cause of serious morbidity and death in these patients. The diagnosis of HAEC is made based on clinical signs and symptoms which are often non-specific, making it difficult to establish a definitive diagnosis in many patients. The purpose of this guideline is to present a rational, expert-based approach to the diagnosis and management of HAEC.

Methods

The American Pediatric Surgical Association Board of Governors established a Hirschsprung Disease Interest Group. Group discussions, literature review, and expert consensus were then used to summarize the current state of knowledge regarding diagnosis, management, and prevention of Hirschsprung-associated enterocolitis (HAEC).

Results

Guidelines for the diagnosis of HAEC and its clinical grade, utilizing clinical history, physical examination findings, and radiographic findings, are presented. Treatment guidelines, including patient disposition, diet, antibiotics, rectal irrigations and surgery, are presented.

Conclusions

Clear, standardized definitions of Hirschsprung-associated enterocolitis and its treatment are lacking in the literature. This guideline serves as a first step toward standardization of diagnosis and management.

Level of evidence

V.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. 1.

    Haricharan RN, Seo J-M, Kelly DR et al (2008) Older age at diagnosis of Hirschsprung disease decreases risk of postoperative enterocolitis, but resection of additional ganglionated bowel does not. J Pediatr Surg 43:1115–1123. doi:10.1016/j.jpedsurg.2008.02.039

    Article  PubMed  Google Scholar 

  2. 2.

    El-Sawaf M, Siddiqui S, Mahmoud M et al (2013) Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled,multicenter trial. J Pediatr Surg 48:111–117. doi:10.1016/j.jpedsurg.2012.10.028

    Article  PubMed  Google Scholar 

  3. 3.

    Ward NL, Pieretti A, Dowd SE et al (2012) Intestinal aganglionosis is associated with early and sustained disruption of the colonic microbiome. Neurogastroenterol Motil 24:874–400. doi:10.1111/j.1365-2982.2012.01937.x

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Pierre JF, Barlow-Anacker AJ, Erickson CS et al (2014) Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung’s disease. J Pediatr Surg 49:1242–1251. doi:10.1016/j.jpedsurg.2014.01.060

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Yan Z, Poroyko V, Gu S et al (2014) Biochemical and biophysical research communications. Biochem Biophys Res Commun 445:269–274. doi:10.1016/j.bbrc.2014.01.104

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Frykman PK, Nordenskjöld A, Kawaguchi A et al (2015) Characterization of bacterial and fungal microbiome in children with Hirschsprung disease with and without a history of enterocolitis: a multicenter study. PLoS One 10:e0124172. doi:10.1371/journal.pone.0124172

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Thiagarajah JR, Yildiz H, Carlson T et al (2014) Altered goblet cell differentiation and surface mucus properties in Hirschsprung disease. PLoS One 9:e99944. doi:10.1371/journal.pone.0099944.t001

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Yildiz HM, Carlson TL, Goldstein AM, Carrier RL (2015) Mucus barriers to microparticles and microbes are altered in Hirschsprung’s disease. Macromol Biosci 15:712–718. doi:10.1002/mabi.201400473

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Gosain A, Barlow-Anacker AJ, Erickson CS et al (2015) Impaired cellular immunity in the murine neural crest conditional deletion of endothelin receptor-B model of Hirschsprung’s disease. PLoS One 10:e0128822. doi:10.1371/journal.pone.0128822

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Frykman PK, Cheng Z, Wang X, Dhall D (2015) Enterocolitis causes profound lymphoid depletion in endothelin receptor B- and endothelin 3-null mouse models of Hirschsprung-associated enterocolitis. Eur J Immunol 45:807–817. doi:10.1002/eji.201444737

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Cheng Z, Dhall D, Zhao L et al (2010) Murine model of Hirschsprung-associated enterocolitis. I: phenotypic characterization with development of ahistopathologic grading system. J Pediatr Surg 45:475–482. doi:10.1016/j.jpedsurg.2009.06.009

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Pastor AC, Osman F, Teitelbaum DH et al (2009) Development of a standardized definition forHirschsprung’s-associated enterocolitis:a Delphi analysis. J Pediatr Surg 44:251–256. doi:10.1016/j.jpedsurg.2008.10.052

    Article  PubMed  Google Scholar 

  13. 13.

    Bell MJ, Ternberg JL, Feigin RD et al (1978) Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187:1–7

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Frykman PK, Short SS (2012) Hirschsprung-associated enterocolitis: prevention and therapy. YSPSU 21:328–335. doi:10.1053/j.sempedsurg.2012.07.007

    Google Scholar 

  15. 15.

    Wang X, Li Z, Xu Z et al (2015) Probiotics prevent Hirschsprung’s disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Colorectal Dis 30:105–110. doi:10.1007/s00384-014-2054-0

    Article  PubMed  Google Scholar 

  16. 16.

    Patrus B, Nasr A, Langer JC, Gerstle JT (2011) Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg 46:184–187. doi:10.1016/j.jpedsurg.2010.09.089

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Consortia

Corresponding authors

Correspondence to Ankush Gosain or Allan M. Goldstein.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gosain, A., Frykman, P.K., Cowles, R.A. et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int 33, 517–521 (2017). https://doi.org/10.1007/s00383-017-4065-8

Download citation

Keywords

  • Hirschsprung disease
  • Hirschsprung’s disease
  • Enterocolitis
  • Hirschsprung-associated enterocolitis
  • Hirschsprung’s-associated enterocolitis